Download - Cryptococcosis main doc
-
8/7/2019 Cryptococcosis main doc
1/19
Cell structure of Cryptococcus fungi
-
8/7/2019 Cryptococcosis main doc
2/19
What is Cryptococcosis ?
Cryptococcosis is infection with Cryptococcus neoformans fungus .
Etiology and incidence
Cryptococcosis is nearly always caused by Cryptococcus neoformans, an encapsulated
yeast (Division Basidiomycota). Unlike most pathogenic fungi, this organism
occurs in the yeast form both in the host and in the environment. The perfect (mycelial)
stage of this fungus is called Filobasidiella neoformans or Filobasidiella bacillisporus.
This stage has never been isolated from patients or found in nature; it is only found in
the laboratory under certain conditions.
C. neoformans is surrounded by a large capsule within its hosts and on some culture
media. This capsule is important in its resistance to phagocytosis and in the identification
of the organism. Strains differ in their virulence for animals and possibly humans,
but the immune status of the host seems to be more important than the virulence of the
strain. There are four serotypes - A, B, C and D - based on capsular antigens . There are
three varieties:
Serotype A now classified as variety grubii
Serotypes B + C variety gattii
Serotype D variety neoformans
-
8/7/2019 Cryptococcosis main doc
3/19
Cryptococcus neoformans var. neoformans comprises serotypes A and D . This
organism is ubiquitous and causes most cases of cryptococcosis. In humans, it is an
opportunistic pathogen that mainly affects immunocompromised hosts.
Cryptococcus neoformans var. gattii comprises serotypes B and C . This variety is
less common in the environment than C. neoformans var neoformans. In humans, it is
mainly found in immunocompetent hosts. It has also been isolated from some cases of
cryptococcosis in animals including cats, dogs, porpoises and llamas.
There are two perfect states of C. neoformans: Filobasidiella neoformans var neoformans
is the result of mating between C. neoformans var neoformans serotypes A and D.
Filobasidiella bacillisporus is the result of mating between C. neoformans var gattii
serotypes B and C.
Some strains of serotypes A and D can mate with strains of serotypes B and C.
Cryptococcus species other than C. neoformans are, with rare exceptions, considered to
be saprophytic and nonpathogenic.
Cryptococcus laurentii has been associated with 15
cases of human disease. These cases mainly occurred in hosts with diseases or conditions
that predisposed them to fungal infections .
-
8/7/2019 Cryptococcosis main doc
4/19
Cryptococcus lifecycle
E xists in asexual and sexual forms, with the asexual form existing as a yeast, which
reproduces by budding. This is the only form associated with human infection.
P roduces white mucoid colonies in vitro which become visible within 48 hours
Thick capsule visible in India ink suspension .
Capsule has important antiphagocytic properties
Cryptococcus epidemiology
-
8/7/2019 Cryptococcosis main doc
5/19
Increasing proportions of patients have an underlying immune deficiency virtually all Var
neoformans or Var grubii
HIV/AIDS
Accounts for up to 50% cryptococcal infections
CD 4 less than 200
Incidence has declined in Australia since advent HAART
P rolonged steroid therapy
Organ transplantation
Malignancy
Sarcoidosis
In contrast to Var neoformans, Var gattii is geographically restricted to:
Australia, PNG
N . Africa and Mediterranean
India, S E Asia
Mexico, Brazil, P araguay, S California
Commonly non-immunocompromised hosts
L arge mass lesions (cryptococcomas) common, resulting in significant morbidity.
Transmission
C. neoformans grows naturally in the environment. C. neoformans Var neoformans
is ubiquitous in the soil, where it grows as a saprophyte. It is common in old pigeon nests
and around pigeon droppings; the bird droppings appear to create a favorable environment
-
8/7/2019 Cryptococcosis main doc
6/19
for its growth. It can also be isolated from numerous environmental sources including
vegetables and fruit, house dust, air conditioners, air and sawdust. It can survive for
months to years outside the host.
C. neoformans Var gattii is found in bark and plant debris under eucalyptus trees
(the river red gum tree E ucalyptus camaldulensis and the forest red gum tree, E . tereticornis).
It is also found in the air around these trees, particularly when they bloom in late
spring. It is not associated with pigeon droppings. Recently, C. neoformans Var gattii
was isolated from trees and soil on Vancouver Island in British Columbia.
Transmission seems to be mainly by inhalation, but C. neoformans can also enter
the body through the skin. Infections seem to be acquired mainly from the environment.
Cryptococcosis can also result from the reactivation of a latent infection.
Cryptococcal mastitis in cattle is usually associated with the treatment of the mammary gland
for another condition. The organism may be introduced into the teat in contaminated
syringes, cannulas or antibiotic preparations. It can also enter the mammary gland if the teat
ends are not adequately cleaned before treatment.
Cryptococcosis does not seem to be very contagious. There are no reports of transmission
from mammalian animals to other animals or to humans. However, in one recent
case, an immunosuppressed human probably acquired C.neoformans from the feces of an
asymptomatic pet bird.
-
8/7/2019 Cryptococcosis main doc
7/19
Human-to-human transmission is extremely rare and has mainly occurred under unusual
circumstances. Vertical transmission was recently described, when a HIV-positive
mother with peri-partum cryptococcal meningitis infected her newborn.
S ymptoms
y
Blurred vision or double vision (diplopia)
y
Bone pain or tenderness of the breastbone (sternum)
y
Chest pain
y
Confusion
y
Cough -- dry
y
Fatigue
y
Fever
y
Headache
y
N ausea
y
Skin rash, including pinpoint red spots (petechiae), ulcers, or other skin lesions
y
Sweating -- unusual, excessive at night
y
Swollen glands
y
Unintentional weight loss
N ote: P eople with a normal immune system may have no symptoms at all.
Diagnosis
P hysical examination may reveal:
-
8/7/2019 Cryptococcosis main doc
8/19
y
Abnormal breath sounds
y
Fast heart rate
y
Fever
y
Mental status changes
y
Stiff neck
Tests that may be done include:
y
Blood culture
y
CT scan of the heady
Sputum culture and stain
y
L ung biopsy
y
Bronchoscopy
y
Spinal tap to obtain a sample of cerebrospinal fluid (CSF)
y
Cerebrospinal fluid (CSF) culture and other tests to check for signs of infection
y
Chest xray
y
L umbar pucture
y
Measure and record opening pressure
-
8/7/2019 Cryptococcosis main doc
9/19
y
Repeat at least fortnightly during therapy and daily if pressure is more than 25 cmH 2O
I ndia ink examination
y
CSF WCC (usually mononuclears) typically low (< 50) in those with advanced
immunosuppression
y
CSF glucose + protein often only minimally abnormal
India Ink preparation taken from SAB isolate showing numerous Cryptococcal cells
surrounded by clear capsule (negative staining)
(Inset: E nlarged photo of Cryptococcal cell & budding daughter cell surrounded by clear
capsule )
Cryptococcal antigen assay
Cryptococcal antigen test (looks for a certain molecule that the Cryptococcus fungus can shed
into the blood.)
-
8/7/2019 Cryptococcosis main doc
10/19
y
Rapid diagnostic test
y
Rare false positives
y
Titre generally correlates to organism burden
y
Serum assay useful screen in AIDS patients
y
Extraneural cultures
y
Occasionally positive from another site
y
Full evaluation needed to exclude disseminated disease, or C N S disease
y
R adiology - Detection of cryptococcomas,may detect hydrocephalus ( need for shunt)
Cryptococcus neoformans in sputum Alcian blue- P AS stain ..
Clinical Manifestations
P ulmonary cryptococcosis
-
8/7/2019 Cryptococcosis main doc
11/19
Asymptomatic carriage may occur in healthy people as well as those with
chronic lung disease
May experience a self limited pneumonia
Invasive chronic pulmonary disease may occur and may disseminate to the
CN S
CN S disease
Meningitis (85%), meningoencephalitis, cryptococcoma
G enerally symptoms more insidious and of longer duration in the non-
immunosuppressed
Higher burden of organisms in AIDS, with variable inflammatory response,
which parallels degree of immunosuppression.
Cutaneous cryptococcosis
Ulcerated or nodular lesions usually portend poor prognosis in disseminated
disease
Cellulitis
Cryptococcus, cutaneous on the hand Cryptococcosis on the forehead
Bone and joint disease
-
8/7/2019 Cryptococcosis main doc
12/19
L ytic lesions in up to 10% with disseminated disease
O cular cryptococcosis
Rare, other than pressure effects
G enitourinary disease
P rostate acts as sanctuary site in immunosuppressed
What Makes Cryptococcus neoformans a P athogen?
To be classified as a pathogen, an organism must be able to cause infection under certain
conditions. By this definition, C. neoformans can certainly be classified as a pathogen. Because
the immunodeficient are more susceptible than the immunocompetent to infection with this
yeast-like organism, C. neoformans is frequently referred to as an opportunistic pathogen.
The factors that make C. neoformans a pathogen can be divided into two major groups:
The first comprises the basic characteristics needed to establish an infection and survive in the
human host
The second comprises the virulence factors that affect the degree of pathogenicity.
Basic Characteristics for P athogenicity
-
8/7/2019 Cryptococcosis main doc
13/19
T he I nfectious P article
Cryptococcus neoforma ns is an encapsulated fungal organism ( F igure 1) that can cause disease
in apparently immunocompetent, as well as immunocompromised, hosts. To enter the alveolar
spaces of the lungs and establish pulmonary infection, an organism must produce viable forms
smaller than 4 m in diameter. The typical vegetative form of C. neoformans is the yeast form
with a cell diameter of 2.5 m to 10 m.
The organism can also undergo sexual reproduction, and since it is a basidiomycete
(Filobasidiella neoformans), it forms basidiospores. Sexual reproduction appears to occur much
less frequently in nature than asexual or vegetative reproduction. The sexual spores
(basidiospores) are approximately 1.8 m to 3 m in diameter .Although the exact nature of the
infectious particles of C. neoformans is not known, they are presumed to be the dehydrated yeast
cells or basidiospores of the appropriate size range to get into the lungs. Once inside the lungs,
the yeast cells become rehydrated and acquire the characteristic polysaccharide capsule (F igure
2)In the case of basidiospores, they would convert to encapsulated blastoconidia.
F igure 1. T ransmission electron micrograph C. neoformans showing the characteristic
polysaccharide capsule.
-
8/7/2019 Cryptococcosis main doc
14/19
F igure 2. P roposed means of infection by C. neoformans .
G rowth I n Vivo
To cause infection in humans, a C. neoformans isolate must grow at 37 oC in an atmosphere of
approximately 5% CO 2 and at a pH of 7.3 to 7.4. To survive at 37 oC, the organism must have an
intact gene that encodes the C. neoformans calcineurin A catalytic subunit Calcineurin is a
serine-threonine specific phosphatase that is activated by Ca 2+-calmodulin and is involved in
stress responses in yeasts . Although calcineurin A mutant strains of C. neoformans can grow at
24oC, they cannot survive in vitro at 37 oC, in 5% CO 2, or at alkaline pH Since these are similar
to conditions in the host, one would predict that the calcineurin A mutant would not survive in
the human host. In support of that prediction, Odom et al. have shown that such mutants are not
pathogenic for immunosuppressed rabbits . Calcineurin A appears to be a basic requirement
-
8/7/2019 Cryptococcosis main doc
15/19
for C. neoformans survival in the host and consequently is a necessary factor for the
pathogenicity of the organism.
Virulence F actors
Virulence factors increase the degree of pathogenicity of a microbe. C. neoforma ns has a number of
virulence factors; generally, the virulence of an isolate cannot be attributed to any single factor, but rather
it is attributed to many working in unison to cause progressive disease. As virulence factors go, those
of C. neoforma ns would be considered low-grade. The severity of the host's disease results from a
combination of several virulence factors superimposed on the host's innate and immune resistance status.
T he fungus has the following essential virulence factors:
S ynthesis of the pigment melanin. Melanin protects the fungal cells against oxidative stress,
phagocytosis, and antifungal drugs, and also can modify host immune responses.
Development of polysaccaride capsule, which helps the fungus cells to withstand phagocytosis
by alveolar macrophages.
Ability to grow at body temperature (37-39C). The vast majority of fungal species grow
optimally between 25 and 35C and there are only a few fungal species that appear
thermotolerant and this physical characteristic is a pre-requisite phenotype for invasive mycoses
in a mammalian host. Furthermore, C. neoformans cells can survive in the gastrointestinal tract
of birds (~40C), which in many instance responsible for environmental spread of the pathogen.
-
8/7/2019 Cryptococcosis main doc
16/19
Neurotropism
T here are three possible hypotheses that can explain the pathogen's predilection for the
Central Nervous S ystem (CN S ):
1. Specific neuronal substrates such as dopamine and epinephrine can facilitate fungal growth;
2. Being a privileged tissue site in terms of vigorousness of immune responses, the C N S might
provide safer environments for the fungus then other body sites;
3. Specific receptors present on neuronal cells could be more attractive for Cryptococcus cells
than other organs during systemic infection.
P athophysiology
Of the 19 species that comprise the genus Cryptococcus, human disease is associated with only C
neoformans. Animal models provide much of the understanding of the pathogenesis and the host
defense mechanisms involved in C neoformans infections. The organism is primarily transmitted
via the respiratory route and not directly from human to human.
Following inhalation, the yeast are deposited into the pulmonary alveoli, where they must
survive the neutral-to-alkaline pH and physiologic concentrations of carbon dioxide before they
are phagocytized by alveolar macrophages. G lucosylceramide synthase ( G CS) has recently been
identified as an essential factor in the survival of C neoformans in this extracellular environment.
Although G CS is a critical factor in extracellular survival of the yeast, the yeast no longer
requires G CS to survive the intracellular, more acidic, environment of within the macrophage
once it is phagocytized by alveolar macrophages.
-
8/7/2019 Cryptococcosis main doc
17/19
Unencapsulated yeast are readily phagocytosed and destroyed, whereas encapsulated organisms
are more resistant to phagocytosis. A cryptococcal polysaccharide capsule has antiphagocytic
properties and may be immunosuppressive. The antiphagocytic properties of the capsule block
recognition of the yeast by phagocytes and inhibit leukocyte migration into the area of fungal
replication.
The host response to cryptococcal infection includes both cellular and humoral components.
Animal models demonstrate that natural killer cells participate in the early killing of cryptococciand, possibly, antibody-dependent cell-mediated killing. In vitro monocyte-derived
macrophages, natural killer cells, and T lymphocytes can inhibit or kill cryptococci. A successful
host response includes an increase in helper T-cell activity, skin test conversion, and a reduction
in the number of viable organisms in the tissues. In addition to cellular mechanisms,
anticryptococcal antibodies and soluble anticryptococcal factors have been described. Antibodies
to a cryptococcal antigen and its complement play a critical role in enhancing the macrophage-
and lymphocyte-mediated immune response to the organism. Researchers use monoclonal
antibodies to capsular polysaccharide to passively immunize mice against C neoformans.
C neoformans infection is usually characterized by little or no necrosis or organ dysfunction until
late in the disease. Organ damage may accelerate in persons with heavy infections. The lack of
identifiable endotoxins or exotoxins partly causes the absence of extensive necrosis early in
cryptococcal infections. Organ damage is primarily due to tissue distortion secondary to the
expanding fungal burden. E xtensive inflammation or fibrosis is rare. The characteristic lesion of
-
8/7/2019 Cryptococcosis main doc
18/19
C neoformans consists of a cystic cluster of yeast with no well-defined inflammatory response.
Well-formed granulomas are generally absent.
C neoformans can cause an asymptomatic pulmonary infection followed later by the
development of meningitis, which is often the first indication of disease. If limited to the lungs,
C neoformans infection may cause pneumonia, poorly defined mass lesions, pulmonary nodules,
and, rarely, pleural effusion. Although immune defects are common in patients with meningitis
or disseminated infection, patients with disease that is confined to the lungs are usually
immunocompetent.
T reatment
CN S disease uniformly fatal without prescription.
Immunocompromised patients need longterm suppressive therapy, unless immune status
substantially recovers
Aim for complete eradication of organism in the nonimmunosuppressed:
Amphotericin B 0.5-0.7 mg/kg/d + flucytosine 100-150 mg/kg/d for 6 weeks followed by
fluconazole 400 mg/d for 3-6 months+
Debate re switch to fluconazole after 2 weeks if favourable clinical(including L P )
response
In HIV/AIDS most switch early to oral therapy, or use high dose oral fluconazole from the
outset if mild disease
L iposomal amphotericin, if develop toxicity.
-
8/7/2019 Cryptococcosis main doc
19/19
N ew azoles
E chinocandins have no anticryptococcal activity
Management of raised intracranial pressure often the most problematic issue
L arge volume (30-50 m L ) CSF removal up to daily
Shunt or drain placement (does not prevent clearance of infection)
Steroids generally of no use in management of pressure, except where oedema
associated with cryptococcomas